miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses

Immunology

Volumn 143, Issue 3, 2014, Pages 478-489

  Singh, Udai P ^a   Murphy, Angela E ^a   Enos, Reilly T ^a   Shamran, Haidar A ^b   Singh, Narendra P ^a   Guan, Honbing ^a   Hegde, Venkatesh L ^a   Fan, Daping ^a   Price, Robert L ^a   Taub, Dennis D ^c   Mishra, Manoj K ^d   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b AL NAHRAIN UNIVERSITY   (Iraq)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d ALABAMA STATE UNIVERSITY   (United States)

Author keywords

Crohn's disease; Inflammatory bowel disease; MiR 155 ; T helper type 1 type 17; Ulcerative colitis

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR9; GLYCOPROTEIN P 15095; MICRORNA 155; CYTOKINE; DEXTRAN SULFATE; MICRORNA; MIRN155 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; EXPERIMENTAL COLITIS; FEMALE; LAMINA PROPRIA; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; SPLEEN; TH1 CELL; TH17 CELL; ANIMAL; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD11C; BODY WEIGHT; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MICE; MICE, KNOCKOUT; MICRORNAS; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH17 CELLS;

EID: 84908270734     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12328     Document Type: Article

References (43)

1. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991; 325:928-37.
2. Dohi T, Fujihashi K, Kiyono H, Elson CO, McGhee JR. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis. Gastroenterology 2000; 119:724-33.
3. Braegger CP, MacDonald TT. Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy 1994; 72:135-41.
4. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52:65-70.
5. Pene J, Chevalier S, Preisser L et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180:7423-30.
6. Yen D, Cheung J, Scheerens H et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116:1310-6.
7. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006; 12:382-8.
8. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 2004; 110:55-62.
9. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10:111-22.
10. O'Connell RM, Kahn D, Gibson WS et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010; 33:607-19.
11. Tili E, Michaille JJ, Cimino A et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179:5082-9.
12. Rodriguez A, Vigorito E, Clare S et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316:608-11.
13. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103:12481-6.
14. Lu C, Huang X, Zhang X et al. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 2011; 117:4293-303.
15. Zhou H, Huang X, Cui H, Luo X, Tang Y, Chen S, Wu L, Shen N. miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 2010; 116:5885-94.
16. Takagi T, Naito Y, Mizushima K et al. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol 2010; 25(Suppl. 1):S129-33.
17. Fasseu M, Treton X, Guichard C et al. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS ONE 2010; 5. doi: 10.1371/journal.pone.0013160.
18. Oertli M, Engler DB, Kohler E, Koch M, Meyer TF, Muller A. MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic gastritis and colitis. J Immunol 2011; 187:3578-86.
19. Singh UP, Singh NP, Singh B, Hofseth LJ, Price RL, Nagarkatti M, Nagarkatti PS. Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-κB activation to abrogate dextran sulfate sodium-induced colitis. J Pharmacol Exp Ther 2010; 332:829-39.
20. -/- mice. J Immunol 2003; 171:1401-6.
21. -/- mice. Brain Behav Immun 2012; 26:72-82.
22. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182:1281-90.
23. Parronchi P, Romagnani P, Annunziato F et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997; 150:823-32.
24. + T cells. Immunity 1994; 1:553-62.
25. Gorelik L, Flavell RA. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000; 12:171-81.
26. Tang Y, Luo X, Cui H et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60:1065-75.
27. Wu F, Zikusoka M, Trindade A et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2α. Gastroenterology 2008; 135:1624-35, e24.
28. + T cells. Eur J Immunol 2010; 40:225-31.
29. Elson CO, Beagley KW, Sharmanov AT et al. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 1996; 157:2174-85.
30. Singh UP, Singh S, Weaver CT, Iqbal N, McGhee JR, Lillard JW Jr. IFN-γ-inducible chemokines enhance adaptive immunity and colitis. J Interferon Cytokine Res 2003; 23:2000.
31. Yu Q, Zhu S, Zhou R et al. Effects of sinomenine on the expression of microRNA-155 in 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice. PLoS ONE 2013; 8:e73757.
32. Hu R, Huffaker TB, Kagele DA, Runtsch MC, Bake E, Chaudhuri AA, Round JL, O'Connell RM. MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression. J Immunol 2013; 190:5972-80.
33. + and CD8+ T cells. J Immunol 2000; 164:2890-6.
34. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9:10-6.
35. - dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur J Immunol 2003; 33:143-51.
36. Autenrieth IB, Bucheler N, Bohn E, Heinze G, Horak I. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 1997; 41:793-800.
37. Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, Poindron P, Duclos B. Increased production of tumour necrosis factor-α interleukin-1β, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996; 39:684-9.
38. Gaetke LM, Oz HS, de Villiers WJ, Varilek GW, Frederich RC. The leptin defense against wasting is abolished in the IL-2-deficient mouse model of inflammatory bowel disease. J Nutr 2002; 132:893-6.
39. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84:4008-27.
40. Ehrhardt RO, Ludviksson BR, Gray B, Neurath M, Strober W. Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 1997; 158:566-73.
41. Visperas A, Do JS, Bulek K, Li X, Min B. IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice. Mucosal Immunol 2014; 7:625-33.
42. Sutton CE, Mielke LA, Mills KH. IL-17-producing γδ T cells and innate lymphoid cells. Eur J Immunol 2012; 42:2221-31.
43. + T cells display CCR9-dependent and -independent homing to the small intestine. Blood 2006; 107:3447-54.